Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021
HomeCamber Spine TechnologiesFirst Implantation Of SPIRA®-O Open Matrix OLIF

First Implantation Of SPIRA®-O Open Matrix OLIF

Reported by Camber Spine Technologies

Camber Spine, a leading innovator in spine and medical technologies, today announced the implantation of their first oblique lumbar interbody fusion (OLIF) specific device from the SPIRA® family using the company’s proprietary SPIRA®-O Open Matrix OLIF, a unique, interbody fusion implant consisting of spiral support arches and Surface by Design™ technology.

Dr. Jeffrey McConnell, MD of Allentown, PA was the first surgeon to clinically implant the SPIRA®-O device into a patient: “I have been a long-time supporter of the SPIRA® technology from Camber Spine, like other SPIRA® products this is a solid performer in terms of strength, ease of insertion, and I appreciate the surface texturing which encourages fusion between the bone and the implant.  I see faster and more robust fusions in all my patients.  Now that Camber has developed an implant that is specific to the anterior to psoas approach, I am able to access all levels of the lumbar spine from one patient position, and the SPIRA®-O instrumentation and design has enabled me with the ability to place deformity corrective sized implants in each level without the complications associated with utilizing risky orthogonal moves. This product is a great addition to the SPIRA® line and makes OLIF’s easier”.

The SPIRA®-O is a deliberately designed implant with a straight in-line insertion taking advantage of a natural corridor for an oblique, anterior to psoas, approach while the patient is in a lateral position.  The SPIRA®-O is specifically designed with implant configurations, lordotic angles and associated instruments to access all levels of the lumbar spine without an orthogonal maneuver.  The SPIRA®-O also incorporates Camber Spine’s proprietary technology Surface by Design® and its patented arch design for redistribution of load and decreased subsidence while maximizing bone graft volume.

Daniel Pontecorvo, CEO of Camber Spine, stated “The SPIRA®-O is a monumental leap forward in Camber’s single position platform.  By incorporating our patented and proven open architecture design with surgeon innovations in access and approach to the lumbar spine, Camber has figured out how to address complex spine pathologies from one approach angle where others have failed to innovate.  This area of the spine calls for specific implants and instruments to be created to give the surgeon the best results, Camber has now created a device specific for the OLIF approach while most other companies continue to repurpose their existing lateral platforms, without success. SPIRA®-O and our upcoming training labs will transform the way surgeons are treating lumbar deformity.”

The SPIRA®-O device is being evaluated by the surgeon design team for the next 90 days with an expected full nationwide launch during late September.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy